| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.006 |